Immunohistochemistry Digital Breast Cancer Panel 3 Test
Introduction to the Test
The Immunohistochemistry Digital Breast Cancer Panel 3 Test is a specialized diagnostic procedure that plays a crucial role in the detection and management of breast cancer. This test utilizes advanced immunohistochemical techniques to analyze tumor samples, helping oncologists determine the presence of specific biomarkers associated with breast cancer. Early diagnosis is essential for effective treatment, and this panel provides invaluable information that can guide therapeutic decisions.
What the Test Measures
This test measures several critical components in breast cancer tissue samples, including:
- Estrogen Receptors (ER)
- Progesterone Receptors (PR)
- HER-2 Status
- Photomicrograph Analysis
- Pathologist Review for Malignant Cells
Who Should Consider This Test?
Individuals who should consider undergoing the Immunohistochemistry Digital Breast Cancer Panel 3 Test include:
- Patients diagnosed with breast cancer who require further characterization of their tumor.
- Individuals with a family history of breast cancer.
- Patients showing symptoms such as lumps in the breast, changes in breast shape or size, or unusual discharge.
- Those with risk factors such as age, genetic predisposition, or previous breast conditions.
Benefits of Taking the Test
The Immunohistochemistry Digital Breast Cancer Panel 3 Test offers several benefits:
- Provides critical information to tailor treatment plans for breast cancer patients.
- Aids in predicting the likelihood of cancer recurrence.
- Helps oncologists choose targeted therapies based on hormone receptor status.
- Facilitates early detection and intervention, improving patient outcomes.
- Enhances understanding of tumor biology, leading to personalized medicine approaches.
Understanding Your Results
Results from the Immunohistochemistry Digital Breast Cancer Panel 3 Test will indicate the presence or absence of specific markers in the tumor tissue. Here’s a general guide to understanding your results:
- Positive ER/PR: Indicates that the cancer may respond to hormone therapy.
- HER-2 Positive: Suggests that the cancer may be more aggressive and may benefit from targeted therapies.
- Negative Results: May indicate a different treatment approach is necessary.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry Digital Breast Cancer Panel 3 Test | 140,000 NGN | 200,000 NGN |
How to Book the Test
To book the Immunohistochemistry Digital Breast Cancer Panel 3 Test, please contact us at +2348077798758 or visit our website to schedule your appointment. Ensure you provide a copy of the Histopathology report, indicate the site of biopsy, and share your clinical history for accurate results.
Don’t wait for symptoms to worsen; take control of your health today with the Immunohistochemistry Digital Breast Cancer Panel 3 Test!
